Enhancer Zeste Homolog 2 (EZH2) expression is associated with a shorter time to the first systemic therapy in follicular lymphoma

被引：0
|
作者：
Szumera-Cieckiewicz, A. [1 ]
Sokol, K. [1 ,2 ]
Rymkiewicz, G. [2 ]
Paszkiewicz-Kozik, E. [3 ]
Poleszczuk, J. [4 ]
Borysiuk, A. [2 ]
Kotarska, M. [3 ]
Walewski, J. [3 ]
Prochorec-Sobieszek, M. [5 ]
机构：
[1] Inst Haematol & Transfus Med, Dept Diagnost Haematol, Warsaw, Poland
[2] Maria Sklodowska Curie Inst Oncol Ctr, Dept Pathol & Lab Med, Gliwice, Poland
[3] Maria Sklodowska Curie Inst Oncol Ctr, Dept Lymphoid Malignancies, Gliwice, Poland
[4] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland
[5] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Pathol, Warsaw, Poland
来源：
VIRCHOWS ARCHIV | 2019年 / 475卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-13-004
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [41] Enhancer of Zeste Homologue 2 (EZH2) expression in malignant and benign hepatic tumors
    Dezso, K.
    Szabo, V.
    Bugyik, E.
    Schlachter, K.
    Paku, S.
    Schaff, Z.
    Nagy, P.
    VIRCHOWS ARCHIV, 2012, 461 : S209 - S209
  • [42] Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration
    Kui Fan
    Chuan-long Zhang
    Bo-hui Zhang
    Meng-qi Gao
    Yun-chuan Sun
    Scientific Reports, 12
  • [43] Enhancer of zeste-homolog 2 (EZH2) expression and clinical outcomes in metastatic castrate resistant prostate cancer (mCRPC).
    Giridhar, Karthik
    Costello, Brian Addis
    Sosa, Carlos
    Huang, Haojie
    Kohli, Manish
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [44] Characterization of enhancer of zeste homolog 2 (EZH2) expression, activity, and association with the tumor immune microenvironment in olfactory neuroblastoma (ONB)
    Xue, Elisabetta
    Krause, Harris Benjamin
    Elliott, Andrew
    Mehra, Ranee
    Florou, Vaia
    Kim, Chul
    Soares, Heloisa P.
    Lou, Emil
    Vanderwalde, Ari M.
    Spetzler, David
    Bracken-Clarke, Dara Mark
    London, Nyall R., Jr.
    Gulley, James L.
    Floudas, Charalampos S.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [45] Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration
    Fan, Kui
    Zhang, Chuan-long
    Zhang, Bo-hui
    Gao, Meng-qi
    Sun, Yun-chuan
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [46] Enhancer of Zeste Homolog 2 (EZH2) Over-Expression Is Associated with Metastasis but Not with Local Tumor Characteristics nor with Mortality in Urothelial Carcinoma of the Bladder
    ElMansi, H.
    Aprikian, A.
    Tanguay, S.
    Bachir, B.
    Florianova, L.
    Kassouf, W.
    Brimo, F.
    MODERN PATHOLOGY, 2014, 27 : 226A - 226A
  • [47] Inhibition of Enhancer of Zeste Homolog 2 (EZH2) Expression Is Associated With Decreased Tumor Cell Proliferation, Migration, and Invasion in Endometrial Cancer Cell Lines
    Eskander, Ramez N.
    Ji, Tao
    Huynh, Be
    Wardeh, Rooba
    Randall, Leslie M.
    Hoang, Bang
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (06) : 997 - 1005
  • [48] Next-generation Sequencing Revealed Frequent TP53 mutation in Mantle Cell Lymphoma with Enhancer of Zeste Homolog 2 (EZH2) Expression
    Kim, Do Hwan
    Li, Shaoying
    Kanagal-Shamanna, Rashmi
    Miranda, Roberto
    Vega-Vazquez, Francisco
    Medeiros, L. Jeffrey
    Ok, Chi Young
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 966 - 967
  • [49] Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration and invasion in endometrial cancer cell lines
    Eskander, R.
    Ji, T.
    Huynh, B.
    Wardeh, R.
    Hoang, B.
    Randall, L.
    GYNECOLOGIC ONCOLOGY, 2012, 127 (01) : S5 - S5
  • [50] Enhancer of Zeste Homolog 2 (EZH2) Over-Expression Is Associated with Metastasis but Not with Local Tumor Characteristics nor with Mortality in Urothelial Carcinoma of the Bladder
    ElMansi, H.
    Aprikian, A.
    Tanguay, S.
    Bachir, B.
    Florianova, L.
    Kassouf, W.
    Brimo, F.
    LABORATORY INVESTIGATION, 2014, 94 : 226A - 226A
12345